Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABO Blood Group Antibody Elimination by a Combination of Semiselective Immunoadsorption Therapy and Membrane Filtration

NCT01698736 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01698736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01698736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABO Blood Group Antibody Elimination by a Combination of Semiselective Immunoadsorption Therapy and Membrane Filtration
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2012
Completion date
February 28, 2013
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunology